According to Dechra Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $0.65. In 2022 the company made an earnings per share (EPS) of $0.65 a decrease over its 2021 EPS that were of $0.71.
Year | EPS | Change |
---|---|---|
2022 | $0.65 | -8.28% |
2021 | $0.71 | 75.6% |
2020 | $0.40 | 5.72% |
2019 | $0.38 | -22.18% |
2018 | $0.49 | 34.58% |
2017 | $0.37 | 93.87% |
2016 | $0.19 | -45.87% |
2015 | $0.35 | -69.74% |
2014 | $1.15 | 267.65% |
2013 | $0.31 | 27.56% |
2012 | $0.25 | -14.03% |
2011 | $0.29 | 5.52% |
2010 | $0.27 | 4.94% |
2009 | $0.26 | 0.49% |
2008 | $0.26 | -16.81% |
2007 | $0.31 | 25.08% |
2006 | $0.25 | 10.33% |
2005 | $0.22 | 35.85% |
2004 | $0.16 | 40.79% |
2003 | $0.12 | 2.85% |
2002 | $0.11 | 48.82% |
2001 | $0.07634 |